{
    "nctId": "NCT02809404",
    "briefTitle": "Dried Blood SPOT Analysis of Everolimus in Cancer Patients (SPOT-study)",
    "officialTitle": "Dried Blood SPOT Analysis of Everolimus in Cancer Patients",
    "overallStatus": "COMPLETED",
    "conditions": "Breast Cancer, Renal Cell Carcinoma",
    "studyType": "OBSERVATIONAL",
    "phase": "N/A",
    "allocation": "N/A",
    "primaryPurpose": "N/A",
    "enrollmentCount": 75,
    "primaryOutcomeMeasure": "Correlation everolimus concentration DBS with whole blood",
    "eligibilityCriteria": "Inclusion Criteria:\n\n* Patients currently treated with everolimus for any type of cancer\n* Patients from whom it is possible to collect blood samples\n* At least 18 years of age\n* Able and willing to sign the Informed Consent Form prior to study assessments.\n\nExclusion Criteria:\n\n* None",
    "sex": "ALL",
    "minimumAge": "18 Years",
    "stdAges": "ADULT, OLDER_ADULT"
}